COM:VENUSMEDTECH
杭州启明医疗器械股份有限公司
- Stock
Last Close
5.62
23/07 20:00
Market Cap
2.46B
Beta: -
Volume Today
6.42M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -157.45M - | -299.62M 90.30% | -381.54M 27.34% | -185.84M 51.29% | -377.56M 103.16% | -1.16B 206.27% | -720.88M 37.66% | |
depreciation and amortization | 6.31M - | 10.04M 59.08% | 28.91M 187.82% | 37.71M 30.46% | 51.62M 36.88% | 112.35M 117.65% | ||
deferred income tax | -147K - | 1.48M 1,104.76% | -9.72M 757.89% | 72.45M 845.63% | ||||
stock based compensation | 73.54M - | 235.76M 220.61% | 120.70M 48.80% | 9M 92.54% | ||||
change in working capital | -5.76M - | -101.91M 1,669.87% | -77.40M 24.05% | -139.83M 80.66% | -146.85M 5.02% | -142.32M 3.08% | ||
accounts receivables | -83.72M - | -68.75M 17.87% | -74.13M 7.82% | -7.85M 89.41% | ||||
inventory | -7.99M - | -7.84M 1.77% | -8.70M 10.86% | -37.63M 332.69% | -29.18M 22.45% | -13.68M 53.14% | ||
accounts payables | 83.72M - | 68.75M 17.87% | 74.13M 7.82% | 7.85M 89.41% | ||||
other working capital | 2.23M - | -94.06M 4,323.84% | -68.70M 26.96% | -102.20M 48.76% | -117.67M 15.13% | -128.65M 9.33% | ||
other non cash items | 1.24M - | 2.78M 124.31% | 15.76M 467.41% | -30.50M 293.53% | 15.86M 152.02% | 456.86M 2,779.83% | 720.88M 57.79% | |
net cash provided by operating activities | -82.27M - | -151.47M 84.12% | -303.29M 100.24% | -237.00M 21.86% | -456.92M 92.79% | -729.46M 59.65% | ||
investments in property plant and equipment | -19.47M - | -26.53M 36.30% | -24.53M 7.55% | -124.05M 405.72% | -145.16M 17.02% | -178.77M 23.15% | ||
acquisitions net | -10.41M - | -192.55M 1,750.35% | -6.44M 96.65% | -94.14M 1,361.04% | -175.67M 86.61% | -819.83M 366.69% | ||
purchases of investments | -13.07M - | 11.54M 188.32% | -70.29M - | -419.85M 497.28% | -91.83M 78.13% | |||
sales maturities of investments | 28K - | 13.10M 46,685.71% | 74.27M - | 54.14M 27.10% | ||||
other investing activites | -4.08M - | 292K 107.16% | 3K 98.97% | -83.73M 2,791,166.67% | 33.50M 140.01% | 18.17M 45.76% | ||
net cash used for investing activites | -46.99M - | -194.15M 313.14% | -30.97M 84.05% | -297.94M 862.07% | -653.04M 119.18% | -1.07B 64.20% | ||
debt repayment | -20.12M - | -83.97M 317.36% | -92.97M 10.72% | -120M 29.07% | -4.70M 96.08% | -213.38M 4,440.02% | ||
common stock issued | 2.68B - | 1.03B 61.39% | 1.19B 15.18% | |||||
common stock repurchased | -72.55M - | |||||||
dividends paid | -17.51M - | |||||||
other financing activites | 193.09M - | 537.14M 178.18% | -8.20M 101.53% | 13.45M 264.06% | 294.83M 2,092.70% | 848.52M 187.80% | ||
net cash used provided by financing activities | 172.97M - | 453.17M 161.99% | 2.58B 468.74% | 927.75M 64.00% | 1.39B 49.98% | 635.14M 54.35% | ||
effect of forex changes on cash | 1.87M - | -1.66M 188.55% | 5.25M 416.92% | -97.89M 1,966.29% | -34.40M 64.85% | 90.81M 363.94% | ||
net change in cash | 45.58M - | 105.90M 132.35% | 2.25B 2,023.10% | 294.92M 86.88% | 247.04M 16.23% | -1.08B 535.46% | ||
cash at beginning of period | 13.44M - | 59.02M 339.20% | 164.91M 179.44% | 2.41B 1,363.34% | 2.71B 12.22% | 2.96B 9.12% | 1.88B 36.40% | |
cash at end of period | 59.02M - | 164.91M 179.44% | 2.41B 1,363.34% | 2.71B 12.22% | 2.96B 9.12% | 1.88B 36.40% | 1.88B 0% | |
operating cash flow | -82.27M - | -151.47M 84.12% | -303.29M 100.24% | -237.00M 21.86% | -456.92M 92.79% | -729.46M 59.65% | ||
capital expenditure | -19.47M - | -26.53M 36.30% | -24.53M 7.55% | -124.05M 405.72% | -145.16M 17.02% | -178.77M 23.15% | ||
free cash flow | -101.73M - | -178M 74.97% | -327.82M 84.17% | -361.05M 10.14% | -602.08M 66.76% | -908.23M 50.85% |
All numbers in HKD (except ratios and percentages)